8-K
filed August 27, 2021, 7:59 PM ET
ticker WHWK
CIK 0001422142
M&A
confidence high
sentiment neutral
materiality 0.95
Aerpio completes reverse merger with Aadi, changes name to Aadi Bioscience, raises $155M PIPE
Whitehawk Therapeutics, Inc.
- Former Aadi stockholders received ~0.3172 shares per Aadi share; post-merger ownership: Aadi 29.2%, former Aerpio 15.2%, PIPE 55.6%.
- PIPE financing of $155M from 11.85M shares at ~$13.08/sh; Avoro Capital (affiliated with new director) invested $25M for ~1.91M shares.
- New board of 7 directors: Caley Castelein (Chair), Neil Desai, Anupam Dalal, Karin Hehenberger, Behzad Aghazadeh, Richard Maroun; one vacancy.
- Reverse stock split 15:1, name change to Aadi Bioscience, ticker symbol changes to AADI on Nasdaq effective Aug 27, 2021.
- Contingent value rights (CVRs) issued to former Aerpio stockholders; each CVR entitles holder to 90% of net proceeds from certain milestone payments.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Steven Prelack resigned as Director at Whitehawk Therapeutics, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Joseph Gardner, Ph.D., Steven Prelack, Pravin Dugel, M.D. and Cheryl Cohen resigned from the Board
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Joseph Gardner resigned as Director at Whitehawk Therapeutics, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Joseph Gardner, Ph.D., Steven Prelack, Pravin Dugel, M.D. and Cheryl Cohen resigned from the Board
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Neil Desai was appointed as President, Chief Executive Officer and Secretary at Whitehawk Therapeutics, Inc..
- Action
- appointed
- Role
- President, Chief Executive Officer and Secretary
Exact text from the filing
the Board appointed Neil Desai, Ph.D., as the Company’s President, Chief Executive Officer and Secretary
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Pravin Dugel resigned as Director at Whitehawk Therapeutics, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Joseph Gardner, Ph.D., Steven Prelack, Pravin Dugel, M.D. and Cheryl Cohen resigned from the Board
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Regina Marek was terminated as Vice President, Principal Financial and Accounting Officer at Whitehawk Therapeutics, Inc..
- Action
- terminated
- Role
- Vice President, Principal Financial and Accounting Officer
Exact text from the filing
the Company terminated the employment of Joseph Gardner, Ph.D., the Company’s Principal Executive Officer, and Regina Marek, the Company’s Vice President, Principal Financial and Accounting Officer.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Cheryl Cohen resigned as Director at Whitehawk Therapeutics, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
Joseph Gardner, Ph.D., Steven Prelack, Pravin Dugel, M.D. and Cheryl Cohen resigned from the Board
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Lance Thibault was appointed as interim Chief Financial Officer at Whitehawk Therapeutics, Inc..
- Action
- appointed
- Role
- interim Chief Financial Officer
Exact text from the filing
Lance Thibault as the Company’s interim Chief Financial Officer.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Joseph Gardner was terminated as Principal Executive Officer at Whitehawk Therapeutics, Inc..
- Action
- terminated
- Role
- Principal Executive Officer
Exact text from the filing
the Company terminated the employment of Joseph Gardner, Ph.D., the Company’s Principal Executive Officer, and Regina Marek, the Company’s Vice President, Principal Financial and Accounting Officer.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.